Mr. Edward Fields reports

DIONYMED BRANDS INC. SIGNS DEFINITIVE AGREEMENT FOR AN UP TO US$40 MILLION CREDIT FACILITY

Dionymed Brands Inc. has signed a definitive agreement for a two-year, up to $40-million (U.S.) senior secured credit facility from a syndicate of investors. The credit facility consists of a $15-million (U.S.) term loan facility and a $25-million (U.S.) asset-backed loan facility. Dionymed will draw $13-million (U.S.) following the completion of certain conditions to the satisfaction of the investors. Currently, the syndicate of investors has committed to provide $13-million (U.S.) of the credit facility. Future commitments from existing or future lenders are expected for the full amount. Amounts drawn under the facility will be guaranteed by Dionymed and its subsidiaries and will be secured by all assets of Dionymed and each subsidiary, including inventory, trade receivables and real property.

This credit facility will be used for acquisitions, capital expenditures, refinancing existing debt, working capital and general corporate purposes.

The credit facility provides Dionymed an efficient capital structure as it continues to expand its U.S. operational footprint and product portfolio, through both inorganic and organic growth opportunities. The facility will bear interest at a rate of LIBOR (London interbank offered rate) plus 8 per cent with a commitment fee, an arrangement fee and an annual fee. The credit facility includes up to an aggregate of 7.1 million warrants with warrants issued to investors based on the amount drawn on the credit facility proportionate to the maximum credit facility size of $40-million. Each warrant provides the investor the right to purchase one subordinated voting (common) share and the warrants expire after 36 months. If the credit facility is fully drawn, the warrants would have a weighted average exercise price of $5.16 per share based on the $3.25 share price as of the close of business on Jan. 16, 2019.

"An efficient capital structure is an essential part of Dionymed's strategic plan as we continue our growth trajectory and further scale our operations. Building upon our capital raise in November, 2018, of $35-million, this credit facility provides non-dilutive capital to help us further achieve our aggressive growth goals, which focus on advancing our deal pipeline and building upon our existing cannabis to consumer platform. The cannabis industry will continue to consolidate at an increasing rate and Dionymed is strongly positioned to play a leading role in this stage of the industry's rapid growth. We look forward to continuing to share our progress with investors on our many growth initiatives over the coming year. We want to thank our investment partners for their ongoing commitment and support to our future," commented Edward Fields, chief executive officer of Dionymed.

A copy of the agreement is available on the company's SEDAR profile.

About Dionymed Brands Inc.

Founded in 2017, Dionymed is a multistate cannabis brands and delivery platform, supporting cultivators, manufacturers and award-winning brands in the medical and adult-use cannabis markets. Dionymed sells branded products in every category from flower to vape cartridges, concentrates and edibles. Dionymed serves more than 700 dispensaries and completes over 40,000 direct-to-consumer deliveries each month with its growing portfolio of products and brands.

We seek Safe Harbor.